Showing results (61-70 of 461) with videos related to
Sort By:
Pageof 47
Surgery|November 30, 2013
Predictive power of prothrombin time and serum total bilirubin for postoperative mortality after major hepatectomy with extrahepatic bile duct resectionYukihiro Yokoyama, Tomoki Ebata, Tsuyoshi Igami, et al.International Journal of Clinical Oncology|March 20, 2015
Role of bevacizumab in neoadjuvant chemotherapy and its influence on microvessel density in rectal cancerAtsuki Arimoto, Keisuke Uehara, Toyonori Tsuzuki, et al.Journal of Hepato-Biliary-Pancreatic Surgery|October 3, 2007
Recent advances in the treatment of hilar cholangiocarcinoma: portal vein embolizationYukihiro Yokoyama, Masato Nagino, Hideki Nishio, et al.Digestive Surgery|February 9, 2016
Proposal for a Pancreatic Configuration Index for Determining Patients at High Risk of Pancreatic Fistula Following PancreatoduodenectomyYukihiro Yokoyama, Tomoki Ebata, Tsuyoshi Igami, et al.Diseases of the Colon and Rectum|January 17, 2018
Survival Benefit of Japanese Extended Lymphadenectomy for Clinically Node-Negative and Node-Positive Colorectal CancersAkira Ouchi, Koji Komori, Kenya Kimura, et al.International Journal of Clinical Oncology|February 26, 2018
Impact of RAS/BRAF mutation status in locally advanced rectal cancer treated with preoperative chemotherapyTaihei Oshiro, Keisuke Uehara, Toshisada Aiba, et al.Digestive Surgery|September 25, 2015
Clinical Significance of Para-Aortic Lymph Node Dissection for Advanced or Metastatic Colorectal Cancer in the Current Era of Modern ChemotherapyAtsuki Arimoto, Keisuke Uehara, Takehiro Kato, et al.Surgery Today|October 24, 2015
The feasibility of laparoscopic extended pelvic surgery for rectal cancerHayato Nakamura, Keisuke Uehara, Atsuki Arimoto, et al.Digestive Surgery|March 19, 2016
Effect of Perioperative Synbiotic Treatment on Bacterial Translocation and Postoperative Infectious Complications after PancreatoduodenectomyYukihiro Yokoyama, Takashi Miyake, Toshio Kokuryo, et al.Anticancer Research|May 17, 2019
NEK2 Is an Effective Target for Cancer Therapy With Potential to Induce Regression of Multiple Human MalignanciesToshio Kokuryo, Yukihiro Yokoyama, Junpei Yamaguchi, et al.Pageof 47